Search Results 151-160 of 16797 for pv

1. A Study to Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) in Patients with Polycythemia Vera - Mayo Clinic

   Meet modified World Health Organization (WHO) 2016 diagnostic criteria for polycythemia vera (PV) at the time of clinical diagnosis. 2. Participant must be ...

2. Peripheral artery disease (PAD) - Symptoms and causes - Mayo Clinic

   This common blood flow condition can cause leg pain when walking. Lifestyle changes and medicines can help, but sometimes surgery is needed.

3. HPV vaccine: Who needs it, how it works - Mayo Clinic

   Human papillomavirus, also called HPV, is spread by sexual activity. Some strains of HPV cause genital warts. Other HPV strains can cause cancers.

4. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

   Diagnosis of polycythemia vera (PV), essential thrombocythemia (ET) ... For PV, has failed or is intolerant of standard therapies or refuses to take ...

5. Imetelstat Sodium in Treating Patients with Primary or Secondary Myelofibrosis - Mayo Clinic

   Post-ET/PV MF per the IWG-MRT criteria. High-risk or Intermediate-2 risk MF (as defined by the Dynamic International Prognostic Scoring System [DIPSS-plus]) ...

6. Correlative Biomarker Study in Patients With Myeloproliferative Disorders - Mayo Clinic

   Patients diagnosed with the following Myeloproliferative disorders including: polycythemia vera (PV), idiopathic myelofibrosis (IM), and essential ...

7. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

   ... PV, de Sain-Van der Velden MG, Elvers B, Morrissey MA, Sunny S, Knoll D, Webster D, Frazier DM, McClure JD, Sesser DE, Willis SA, Rocha H, Vilarinho L, John ...

8. A Study to Establish a Research Tissue Bank for Myeloproliferative Neoplasms - Mayo Clinic

   Newly diagnosed subjects diagnosed with Philadelphia chromosome negative myeloproliferative neoplasms (MPN) polycythemia vera (PV), prefibrotic ...

9. Cancer Treatment! Clinical Trials - Mayo Clinic Research

   ... PV MF), or Post-essential Thrombocythemia Myelofibrosis (post-ET MF). Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative ...

10. Ruxolitinib Prior to Transplant in Patients With Myelofibrosis - Mayo Clinic

    Documented diagnosis of primary myelofibrosis according to WHO criteria or post PV myelofibrosis or post ET myelofibrosis as per IWG-MRT criteria; Age 18-70 ...